
A seed and early-stage venture firm backing digital companies in essential industries such as healthcare and energy

Life sciences venture firm supporting biotech and health companies through private financing and public markets

LifeSci Venture Partners backs companies in life sciences as a venture firm. It says its conviction about a company comes from detailed scientific research, and that its support spans company building, private financing and access to public markets. The firm has been investing in clinical-stage innovation since 2017, and presents itself as a team of clinical, scientific and investment specialists.
The firm describes the companies it seeks as ones reshaping medical care through new approaches to molecular medicine, technology or the delivery of healthcare. It looks for entrepreneurs, clinicians and scientists who eat, sleep and breathe innovation, and it focuses on companies that have achieved proof of concept and have a path to public markets within 12 to 18 months. Its terms are described as founder-aligned, with patient and flexible capital. The firm says it carries out rigorous diligence at the start and makes a long-term commitment afterwards.
Portfolio companies can draw on the LifeSci Partners platform, which the firm describes as a global healthcare consultancy with six complementary businesses and more than 200 experienced professionals. The network is presented as a way to accelerate business development at every stage of a company's life.
The firm's milestones list includes a decentralized clinical research company, a San Diego biotechnology company working in oncology, a bioelectronic medicine company focused on chronic disease, and a medical device developer whose system combines several technologies. It also lists a biotechnology company focused on serious metabolic diseases, a clinical-stage company developing a novel small-molecule therapeutic, a San Diego company with chemistry capabilities for drug discovery, a clinical pharmaceutical company developing an eye drop, a specialty pharma company focused on disorders of the nose, and a company developing a first-in-class antibody.
LifeSci Venture Partners is a venture firm working in life sciences. It bases its conviction on detailed scientific research and supports companies through company building, private financing and public market activity.
Its pages list financing rounds and public offerings for a run of biotechnology, medical device and pharmaceutical businesses.
Emerging biopharma and health companies. Named examples include Science 37, a decentralised clinical trials company, Erasca and Rocket Pharma in oncology and gene therapy, Cala Health in bioelectronic medicine, Beta Bionics in medical devices, and Akero, Attune, Metacrine, Orasis, Novus and Allakos.
Summary written by TrustList from the business's own published information, Nov 2026.
2 images - click to enlarge
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about LifeSci Venture Partners.
Similar listings buyers compare against this one.

A seed and early-stage venture firm backing digital companies in essential industries such as healthcare and energy

Investment firm partnering with venture and growth funds to gain exposure to Chinese companies

Corporate venture fund from Merck investing in digital health and healthcare technology companies worldwide

Private equity firm buying software and tech-enabled businesses from owners in North America

London early-stage venture capital investor linked to London Business School, backing patentable deep technology

Life sciences venture fund backing biotech and biopharma companies from seed to later stage across three regions
New York venture capital firm making early and growth stage investments on the East Coast, mostly as co-investor

Growth equity investor partnering with entrepreneurs to scale privately held technology companies
Everything here links back to the same verified catalogue. Pick your next stop.